Nectar Lifesciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Nectar Lifesciences Ltd. on BSE

Load latest

Nectar Lifesciences Ltd.

25 Mar 2010

21.93

0.50%

Corp. Note

Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997

BSE India

NSR Direct PE Mauritius, LLC & Vedanta Opportunities Fund, LP has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE

pdf

Nectar Lifesciences Ltd.

18 Mar 2010

21.93

0.50%

Corp. Note

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

BSE India

Nectar Lifesciences Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

pdf

Nectar Lifesciences Ltd.

15 Mar 2010

21.93

0.50%

Corp. Note

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

BSE India

Nectar Lifesciences Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

pdf

Nectar Lifesciences Ltd.

11 Mar 2010

21.93

0.50%

Corp. Note

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

BSE India

Nectar Lifesciences Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

pdf

Nectar Lifesciences Ltd.

03 Mar 2010

21.93

0.50%

Corp. Note

Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997

BSE India

Nectar Lifesciences Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:

pdf

Nectar Lifesciences Ltd.

03 Mar 2010

21.93

0.50%

Corp. Note

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

BSE India

Nectar Lifesciences Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

pdf

Nectar Lifesciences Ltd.

03 Mar 2010

21.93

0.50%

Corp. Note

NecLife raises Rs. 2520 million

BSE India

Nectar Lifesciences Ltd has informed BSE regarding an Investor Information Release dated March 02, 2010 titled "NecLife raises Rs. 2,520 million""Nectar Lifesciences Ltd (NecLife), a leading Integrated pharmaceutical organization in India, on February 20, 2010 had announced that the company has approved the allotment of twenty six million equity shares at a price of Rs. 35 per share (26,000,000 equity shares of face value of Re. 1 each at...

pdf

Nectar Lifesciences Ltd.

02 Mar 2010

21.93

0.50%

Corp. Note

Revised Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997

BSE India

NSR Direct PE Mauritius, LLC has submitted the revised disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE

pdf

Nectar Lifesciences Ltd.

02 Mar 2010

21.93

0.50%

Corp. Note

Allotment of equity shares underlying GDRs

BSE India

Nectar Lifesciences Ltd has informed BSE that the Global Depository Receipts (GDRs) issue has been fully subscribed and Board of Directors of the Company at their Meeting held on February 26, 2010, have allotted 46,000,000 equity shares of Re. 1/- each underlying 46,000,000 Global Depository Receipts (GDRs) of US$ 0.76 each. The total proceeds from the issue are US$ 34.96 Million....

Nectar Lifesciences Ltd.

26 Feb 2010

21.93

0.50%

Corp. Note

Updates

BSE India

Nectar Lifesciences Ltd has informed BSE that pursuant to the approval received from the shareholders of the Company at the Extraordinary General Meeting held on February 11, 2010, the Company will open its GDRs Issue for subscription on February 26, 2010, and close on same day or as soon as the issue is fully subscribed.The Company expects to raise US $ 34.96 million from this offering.Each GDR represents one underlying share in the Company.

Is Nectar Lifesciences Ltd. worth buying?

155 Votes:

Buy 77.42%

Sell 16.77%

Hold 5.81%